SemaThera Inc
PrivateLast Round
Series A
Mar 21, 2018
Total Funding Raised
$2.76M
Company Overview
SemaThera Inc is a biotechnology company that develops novel inhibitors of semaphorin 3A for the prevention and reversal of retinal vascular diseases such as diabetic retinopathy and diabetic macular edema.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SemaThera Inc Comparables
Compare SemaThera Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AsclepiX Therapeutics | 87% | |
| Memento Medicines | 82% | |
| Boehringer Ingelheim | 73% |
For institutional investors. Book with your work email.
SemaThera Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 21, 2018 | ||||
| Seed | Jan 11, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SemaThera Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AmorChem | Seed |
For institutional investors. Book with your work email.
SemaThera Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SemaThera Inc's valuation, stock price, and market status.
Is SemaThera Inc a public or private company?
SemaThera Inc is a private company.
What is the current stock price of SemaThera Inc?
SemaThera Inc is a private company, so its shares have no public market price. Caplight tracks SemaThera Inc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SemaThera Inc worth (valuation)?
Valuation information for SemaThera Inc is not publicly available.
Can I buy SemaThera Inc stock?
SemaThera Inc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SemaThera Inc's last funding round?
SemaThera Inc's most recent funding round was Series A on March 21, 2018.
Who are the main investors in SemaThera Inc?
Key investors in SemaThera Inc include AmorChem.
Will SemaThera Inc IPO soon?
No public IPO plans have been announced for SemaThera Inc.
How can I track SemaThera Inc secondary market activity?
Caplight tracks bids, offers, and trades in SemaThera Inc's shares on secondary markets.